Demoralization
10
3
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.0%
1 terminated out of 10 trials
80.0%
-6.6% vs benchmark
10%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (10)
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
Effects of a Five-Dimensional Intervention Program Based on Inner Strength on Demoralization Syndrome in Elderly Cancer Patients
Lysergic Acid Diethylamide (LSD) in Palliative Care
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Exploratory Study of Low Dose Psilocybin
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Ketamine-assisted Therapy for Advanced GI Cancer
Spiritual Well-being, Self-compassion, Physical Symptoms Distress and Demoralization Among HD Patients
Demoralization Among Palliative Care Patients and Their Family Caregivers in Hong Kong: A Pilot Study